周梦娇
女，汉族，苏州大学材料科学与工程博士，南通大学药学院讲师。2022-2023年赴香港城市大学化学系开展访学研究。长期致力于抗肿瘤刺激响应型纳米递药系统构建与肿瘤多模态协同治疗研究，专注于肿瘤靶向递送、铁死亡调控、声动力/化学动力学联合治疗等领域。以第一或通讯作者在Advanced Functional Materials, Aggregate, Journal of Controlled Release, Biomaterials, European Journal of Medicinal Chemistry, Nanoscale等国际知名SCI期刊上发表多篇学术论文。先后主持江苏省青年基金、南通市民生科技面上项目等纵向课题，设计构建多种智能抗肿瘤递送平台，为肿瘤协同治疗提供新策略。
教育经历
(1) 2014-09至2018-06，苏州大学，材料科学与工程，博士
(2) 2011-09至2014-06，苏州大学，材料科学与工程，硕士
(3) 2007-08至2011-06，苏州大学，材料科学与工程，学士
工作经历
(1) 2018-07至今，南通大学，药学院，讲师
(2) 2022-04至2023-03，香港城市大学，化学系，助理研究员
研究方向
(1)智能响应型纳米抗肿瘤递药系统构建与制剂研发
肿瘤多模态协同诊疗新策略
在研/主持基金项目
江苏省青年基金项目，江苏省科学技术厅，BK20200977，基于维生素B2的智能响应型纳米药物用于联合治疗的研究，2020-07至2023-06，20万元，结题，主持
国家自然科学基金委员会，联合基金项目，U2032134，重离子放疗协助免疫调节性囊泡对脑胶质瘤的靶向递送和免疫治疗及其机制研究，2021-01-01至2023-12-31，60万元，结题，参与
南通市科学技术局民生科技面上项目，MS12018098，pH/氧化还原双重响应性的无载体纳米抗癌药物用于肿瘤靶向传递及协同治疗，2018.07至2020.06，10万元，主持，已结题
代表性论文
1. Tianyi Wang; Min Long; Cheng Liu; Zhiqiang Xu; Xinlan Xu; Mengjiao Zhou*; Ziyuan Liu*; Genyan Liu*; Colorimetric and fluorescent dual-mode chemosensor for visual detection of carbon monoxide and its applications in environmental analysis and bioimaging, Journal of Photochemistry and Photobiology A: Chemistry, 2026, 479, 1172666.
2.Fanchun Hu; Yuhan Ding; Caiting Deng; Jingjing Zhang; Wei Qu; Yanqin Rong; Nandi Chen*; Mengjiao Zhou*; Feifei An*; SO2 gas potentiator engineered for self-amplifying chemo-radiotherapy in breast tumors, Chinese Chemical Letters, 2025, 112277.
3. Mengjiao Zhou; Minjian Yuan; Yilan Jin; Qiangian Zhou; Yuting Yu; Jianan Li; Xing Dai; Xiaohua Zheng*; Haijun Yu*; Weiqi Wang*; Vitamin B2-based ferroptosis promoter for sono-enhancednanoeatalytic therapy of triple-negative breast cancer, Advanced Functional Materials, 2023,33(52), 2303899.
4.Yuhan Ding; Yuchen Yang; Omer Aras; Feifei An*; Mengjiao Zhou*; Yichao Chai*; Development and Application of Organic Sonosensitizers in Cancer Therapy, Aggregate, 2025, 6(6), e70032.
5. Jiawen Tao; Zhifei Yuan; Mengjiao Zhou*; Targeted Photodynamic Therapy: Enhancing Efficacy through Specific Organelle Engagement, Frontiers in Pharmacology, 2025, 16, 1667812.
6. Jiawen Tao; Zhifei Yuan; Mengjiao Zhou*; Recent advances in mitochondria-targeted porphyrin-based metal-organic frameworks for enhanced cancer therapy, Frontiers in Pharmacology, 2025, 17, 1764901.
7. Biying Han; Yan Liu; Qianqian Zhou; Yuting Yu; Xingxing Liu; Yu Guo; Xiaohua Zheng; Mengjiao Zhou*; Haijun Yu; Weiqi Wang; The advance of ultrasound-enabled diagnostics and therapeutics, Journal of Controlled Release, 2024, 375, 1-19.
8. Meichen Zheng; Jingjing Zhang; Caiting Deng; Lei Chen; Heng Zhang; Jingqi Xin; Omer Aras; Mengjiao Zhou*; Feifei An*; Yu Ren*; The collaborated assembly of hydrophobic curcumin and hydrophilic cyanine dye into nanocolloid for synergistic chemo-photothermal cancer therapy, Materials & Design, 2024, 241, 112900.
9. Yongmei Zhao; Yuanlin Zheng; Yan Zhu; Kai Ding; Mengjiao Zhou*; Tianging Liu*; Co-delivery of gemcitabine and Triapine by calcium carbonate nanoparticles against chemoresistant pancreatic cancer, International Journal of Pharmaceutics, 2023, 636, 122844.
10. Yongmei Zhao; Tianqing Liu; Mengjiao Zhou*, Immune cell-derived exosomes for cancer therapy, Molecular Pharmaceutics, 2022, 19(9), 3042-3056.
11. Mengjiao Zhou; Minjian Yuan; Meng Zhang; Chenyi Lei; Omer Aras; Xiaohong Zhang; Feifei An, Combining histone deacetylase inhibitors (HDACis) with other therapies for cancer therapy, European Journal of Medicinal Chemistry, 2021, 226, 113825.
12. Mengjiao Zhou; Xiao Liu; Fangmin Chen; Lili Yang; Minjian Yuan; Ding-Yi Fu; Weiqi Wang; Haijun Yu, Stimuli-activatable nanomaterials for phototherapy of cancer. Biomedical Materials, 2021, 16, 042008.
13. Mengjiao Zhou; Yuqi Xie; Shujun Xu; Jingqi Xin; Jin Wang; Tao Han; Richard Ting; Jie Zhang; Feifei An, Hypoxia-activated nanomedicines for effective cancer therapy, European Journal of Medicinal Chemistry, 2020, 195, 112274.
14. Mengjiao Zhou; Shupeng Han; Omer Aras; Feifei An, Recent advances in paclitaxel-based self-delivery nanomedicine for cancer therapy, Current Medicinal Chemistry, 2020, 28, 6358-6374.
15. Sena Karaosmanoglu; Mengjiao Zhou; Bingyang Shi; Xiujuan Zhang; Gareth R. Williams; Xianfeng Chen, Carrier-free nanodrugs for safe and effective cancer treatment, Journal of Controlled Release, 2020, 329, 805-832.
16. Mengjiao Zhou; Weijia Wei; Xianfeng Chen; Xiuzhen Xu; Xiaohong Zhang; Xiujuan Zhang, pH and redox dual responsive carrier-free anticancer drug nanoparticles for targeted delivery and synergistic therapy, Nanomedicine: Nanotechnology, Biology and Medicine, 2019, 20, 102008.
17. Mengjiao Zhou; Xiujuan Zhang; Xiuzhen Xu; Xianfeng Chen; Xiaohong Zhang, Doxorubicin@Bcl-2 siRNA core@shell nanoparticles for synergistic anticancer chemotherapy, ACS Applied Bio Materials, 2018, 1(2), 289-297.
18. Mengjiao Zhou; Xiujuan Zhang; Caitong Yu; Xueyan Nan; Xianfeng Chen; Xiaohong Zhang, Shape regulated anticancer activities and systematic toxicities of drug nanocrystals in vivo, Nanomedicine: Nanotechnology, Biology and Medicine, 2015, 12(1), 181-189.
19. Caitong Yu#; Mengjiao Zhou#; Xiujuan Zhang; Weijia Wei; Xianfeng Chen; Xiaohong Zhang, Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis, Nanoscale, 2015, 13(7), 5683-5690.
20. Mengjiao Zhou; Xiujuan Zhang; Yinlong Yang; Zhuang Liu; Baishun Tian; Jiansheng Jie; Xiaohong Zhang, Carrier-free functionalized multidrug nanorods for synergistic cancer therapy, Biomaterials, 2013, 34(35), 8960-8967.
授权专利
1.周梦娇；王伟奇；周茜茜；石艳婷；韩碧莹；一种用于结肠癌治疗的可注射水凝胶的制备方法及其应用，2024-12-10，中国，CN202410574583.2
2.王伟奇，周梦娇，袁敏健，金怡兰，刘宵，周茜茜，一种基于维生素B2的声(光)敏纳米颗粒VFNS的制备方法及其应用，2023-7-28，中国，CN202210370030.6